Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Histrelin Implant vs Zoladex in Metastatic Prostate Cancer
NCT01394263Phase 3Completed
- Sponsor
- Endo International plc
- Start
- May 2000
- Primary completion
- Dec 2001
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 3 trial of histrelin in Metastatic Prostate Cancer (mPC), sponsored by Endo International plc. Started May 2000; status: completed.
02
Drugs
histrelin
03
Conditions
Metastatic Prostate Cancer (mPC)
Beyond the preview
Go deeper on NCT01394263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01394263.